The Primary Lens for Evaluating New Care Models

The Primary Lens for Evaluating New Care Models
By: Women's HealthX Editorial
10/06/2026

52% of health plans say cost reduction is the primary factor influencing their evaluation of virtual-first obstetrics models.

Boston MA -- October 6: As the women's health market continues to mature, health plans are demanding measurable economic value before scaling coverage for new delivery models.

The Women's Health Infrastructure Report 2026 indicates that convenience and member satisfaction are no longer sufficient to secure enterprise-wide contracting.

52%
of health plans identify cost reduction as the most influential factor when evaluating virtual-first care models.

While patient outcomes remain important, economic considerations are now central to purchasing decisions[cite: 9]. The rapid proliferation of digital health platforms has expanded access, but payers absorbing the actuarial risk are prioritizing financial sustainability alongside quality of care.

Factors Most Influencing the Evaluation of Virtual-First Obstetrics Models
Cost reduction
52%
Clinical outcomes
22%
Member satisfaction
15%
Network capacity
11%
"To justify commercial coverage, virtual-first models must transition from merely enhancing the patient experience to actively mitigating high-acuity claims."
Report Editorial Insight
Women's Health Infrastructure Report 2026
What This Means
Payers are demanding concrete evidence that digital platforms can actively reduce the total cost of care—specifically by lowering unnecessary emergency room visits, preventing avoidable C-sections, and reducing costly NICU admissions.

This finding represents just one of dozens of insights uncovered through the Women's Health Infrastructure Report 2026, a cross-sector study bringing together perspectives from health plans, providers, employers, clinicians, life sciences organisations and innovators.

The full report features detailed findings, expert commentary, benchmark data and practical implications for healthcare leaders looking to understand where women's health is heading next.

Lead Research Partner
Foraviset

Women’s HealthX 2026 | From Rhetoric to Results

Encore Boston Harbor | December 3-4 2026

Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.